Gaining Ground: Legend Biotech Corp ADR (LEGN) Closes Lower at 43.61, Down -1.69

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Legend Biotech Corp ADR (NASDAQ: LEGN) closed at $43.61 in the last session, down -1.69% from day before closing price of $44.36. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 0.87 million shares were traded. LEGN stock price reached its highest trading level at $44.78 during the session, while it also had its lowest trading level at $42.86.

Ratios:

We take a closer look at LEGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.78 and its Current Ratio is at 4.84. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.29.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Redburn Atlantic on October 08, 2024, initiated with a Buy rating and assigned the stock a target price of $86.

On June 17, 2024, Truist started tracking the stock assigning a Buy rating and target price of $88.

H.C. Wainwright reiterated its Buy rating for the stock on May 24, 2024, while the target price for the stock was revised from $86 to $73.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 25 ’24 when Huang Ying bought 1,504 shares for $44.10 per share.

Macomber Lori bought 90,060 shares of LEGN for $4,405,003 on Sep 20 ’24. On Sep 20 ’24, another insider, Yau Wai Man Philip, who serves as the Director of the company, bought 1,946 shares for $51.04 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LEGN now has a Market Capitalization of 8036800000 and an Enterprise Value of 15023236096. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.52 while its Price-to-Book (P/B) ratio in mrq is 6.89. Its current Enterprise Value per Revenue stands at 32.946 whereas that against EBITDA is -41.451.

Stock Price History:

Over the past 52 weeks, LEGN has reached a high of $70.13, while it has fallen to a 52-week low of $38.60. The 50-Day Moving Average of the stock is -10.54%, while the 200-Day Moving Average is calculated to be -16.04%.

Shares Statistics:

According to the various share statistics, LEGN traded on average about 995.54K shares per day over the past 3-months and 1159140 shares per day over the past 10 days. A total of 181.91M shares are outstanding, with a floating share count of 181.45M. Insiders hold about 0.94% of the company’s shares, while institutions hold 50.05% stake in the company. Shares short for LEGN as of 1728950400 were 11954714 with a Short Ratio of 12.01, compared to 1726185600 on 10470444. Therefore, it implies a Short% of Shares Outstanding of 11954714 and a Short% of Float of 12.34.

Most Popular